Aglepristone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Aglepristone (INN) (brand name Alizine; former code names RU-46534, RU-534) is a steroidal antiprogestin (progesterone receptor full antagonist) related to mifepristone which is marketed by Virbac in several European countries for use in veterinary medicine.[1][2][3] It is specifically used as an abortifacient in pregnant.[1][3][4] Aglepristone, similarly to mifepristone, also possesses some antiglucocorticoid activity.
References
- ↑ 1.0 1.1 John D. Bonagura; David C. Twedt (1 December 2013). Kirk’s Current Veterinary Therapy XV. Elsevier Health Sciences. pp. 3009–. ISBN 978-0-323-22762-9.
- ↑ E. James Squires (2010). Applied Animal Endocrinology. CABI. pp. 207–. ISBN 978-1-84593-755-3.
- ↑ 3.0 3.1 Mark G. Papich (3 November 2010). Saunders Handbook of Veterinary Drugs: Small and Large Animal. Elsevier Health Sciences. pp. 120–. ISBN 1-4377-0192-2.
- ↑ Patrick W. Concannon (2001). Advances in reproduction in dogs, cats and exotic carnivores: proceedings of the fourth International Symposium on Canine and Feline Reproduction, Oslo, Norway, 29 June-1 July 2000. Journal of Reproduction and Fertility. ISBN 978-0-906545-37-9.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH